Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16820880)

  • 1. Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target.
    Shimokawa T; Matsushima S; Tsunoda T; Tahara H; Nakamura Y; Furukawa Y
    Int J Oncol; 2006 Aug; 29(2):381-6. PubMed ID: 16820880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells.
    Obama K; Kato T; Hasegawa S; Satoh S; Nakamura Y; Furukawa Y
    Clin Cancer Res; 2006 Jan; 12(1):70-6. PubMed ID: 16397026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers.
    Yuki D; Lin YM; Fujii Y; Nakamura Y; Furukawa Y
    Oncol Rep; 2004 Aug; 12(2):275-80. PubMed ID: 15254688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.
    Tsuchiya N; Ochiai M; Nakashima K; Ubagai T; Sugimura T; Nakagama H
    Cancer Res; 2007 Oct; 67(19):9568-76. PubMed ID: 17909068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
    Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
    Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
    Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRF-1 is the major transcription factor regulating the expression of the human TOMM34 gene.
    Blesa JR; Prieto-Ruiz JA; Abraham BA; Harrison BL; Hegde AA; Hernández-Yago J
    Biochem Cell Biol; 2008 Feb; 86(1):46-56. PubMed ID: 18364745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated expression of S100A6 in human gastric cancer.
    Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
    J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor.
    Sakai M; Shimokawa T; Kobayashi T; Matsushima S; Yamada Y; Nakamura Y; Furukawa Y
    Oncogene; 2006 Jan; 25(3):480-6. PubMed ID: 16170351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR signaling pathway is a target for the treatment of colorectal cancer.
    Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
    Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer.
    Takahashi K; Furukawa C; Takano A; Ishikawa N; Kato T; Hayama S; Suzuki C; Yasui W; Inai K; Sone S; Ito T; Nishimura H; Tsuchiya E; Nakamura Y; Daigo Y
    Cancer Res; 2006 Oct; 66(19):9408-19. PubMed ID: 17018595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorting nexin 1 down-regulation promotes colon tumorigenesis.
    Nguyen LN; Holdren MS; Nguyen AP; Furuya MH; Bianchini M; Levy E; Mordoh J; Liu A; Guncay GD; Campbell JS; Parks WT
    Clin Cancer Res; 2006 Dec; 12(23):6952-9. PubMed ID: 17145813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.